WVEWave Life Sciences Ltd.

$3B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$108M-4.4% YoY

Gross Profit

$108M100.0% margin

Operating Income

-$110M-101.9% margin

Net Income

-$97M-89.6% margin

EPS (Diluted)

$-0.70

Cash Flow

Operating Cash Flow

-$151M

Free Cash Flow

-$152M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$352M

Total Liabilities

$143M

Stockholders' Equity

$210M

Cash & Equivalents

$302M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$108M	$113M	-4.4%
Gross Profit	$108M	$113M	-4.4%
Operating Income	-$110M	-$68M	-62.4%
Net Income	-$97M	-$58M	-68.7%

WVE FY 2024 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena